What is ImmunityBio, Inc.'s treasury stock?

ImmunityBio, Inc. (IBRX) reported treasury stock of 163.8K in Q1 2026.

How has ImmunityBio, Inc.'s treasury stock changed year-over-year?

ImmunityBio, Inc.'s treasury stock decreased by 0.0% year-over-year, from 163.8K to 163.8K.

What is the long-term trend for ImmunityBio, Inc.'s treasury stock?

Over 5 years (2020 to 2025), ImmunityBio, Inc.'s treasury stock has grown at a 0.0% compound annual growth rate (CAGR), from 163.8K to 163.8K.

ImmunityBio, Inc. IBRX Treasury Stock

Treasury Stock at other companies

Bristol-Myers SquibbBMY

$43.52B-0.2%

Johnson & JohnsonJNJ

$76.26B+0.5%

Merck & Co.MRK

$63.75B+7.3%

BiogenBIIB

$2.98B0.0%

Regeneron PharmaceuticalsREGN

$19.41B+19.7%

United TherapeuticsUTHR

$5.44B+56.6%

Other financials

Income statement

See full

Revenue$44.2M+168%

Gross profit$44.0M+167%

Operating income-$69.8M-8.3%

Net income-$632.8M-388%

EPS (diluted)-$0.62-313%

Balance sheet

See full

Cash & equivalents$205.2M+238%

Total debt$445.4M+32.2%

Total equity-$870.0M-47.1%

Total assets$646.6M+113%

Cash flow

See full

Operating cash flow-$75.4M+12.3%

CapEx$1.8M+58.4%

Free cash flow-$77.1M+11.4%

Valuation

See full

Market cap$7.71B+208%

Enterprise value$7.95B+187%

P/S54.7×-25.4×

Profitability

See full

Gross margin99.3%-0.5pp

Operating margin-185.4%-83.3pp

Net margin-606.2%-212pp

FCF margin-212%-95.8pp

Returns & leverage

See full

Return on equity-119.3%—

Debt / equity0.1×—

Current ratio6.7×+4.4×

Where this comes from

Reported directly by ImmunityBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: ImmunityBio, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ImmunityBio, Inc.'s treasury stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ImmunityBio, Inc.'s treasury stock?: ImmunityBio, Inc. (IBRX) reported treasury stock of 163.8K in Q1 2026.
How has ImmunityBio, Inc.'s treasury stock changed year-over-year?: ImmunityBio, Inc.'s treasury stock decreased by 0.0% year-over-year, from 163.8K to 163.8K.
What is the long-term trend for ImmunityBio, Inc.'s treasury stock?: Over 5 years (2020 to 2025), ImmunityBio, Inc.'s treasury stock has grown at a 0.0% compound annual growth rate (CAGR), from 163.8K to 163.8K.